Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575328 · ClinicalTrials.gov registry record · Phase 3
Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females
A Phase 3 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 8
- Enrollment target
NCT00575328: Clinical Trial Phase 3 study, sponsored by Massachusetts General Hospital.
NCT00575328 is a Phase 3 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00575328, a Phase 3 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out whether Maca Root is effective for treating sexual dysfunction in females that is caused by the treatment for bipolar disorder. An additional aim of the study is to document the safety and tolerability of maca root, as well as any potential side effects that it causes. We suspect that Maca Root will result in a significant reduction in sexual dysfunction when compared to a placebo group.
Interventions
- DRUG Placebo
- DRUG Maca Root
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-02-26 |
| Est. Completion | 2010-04-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00575328
The ClinicalTrials.gov registry entry for NCT00575328 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00575328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00575328 about?
NCT00575328 is a clinical study titled "Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females". The purpose of this research study is to find out whether Maca Root is effective for treating sexual dysfunction in females that is caused by the treatment for bipolar disorder. An additional aim of the study is to document the safety and tolerability of maca root, as well as any potential side effe...
What is the current status of trial NCT00575328?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 8 participants. The study started on 2008-02-26. Estimated completion is 2010-04-26.
What interventions are being tested in trial NCT00575328?
The interventions under investigation include: Placebo (DRUG), Maca Root (DRUG).
Who is sponsoring clinical trial NCT00575328?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.